Iron path capital-backed puretech scientific completes acquisition of glycolic acid business from the chemours company

Nashville, tenn.--(business wire)--puretech scientific llc today announced the completion of its acquisition of the glycolic acid business from the chemours company (nyse: cc) for $137 million in cash, making puretech scientific a global leader in the organic synthesis of ultra-high purity alpha hydroxy acids for the life sciences and specialty chemical industries. puretech scientific was founded and backed by iron path capital, a private equity firm specializing in lower-middle market investme.
CC Ratings Summary
CC Quant Ranking